Limitations of MELD and MELD 3.0 for prognostication in patients with cirrhosis hospitalized with acute decompensation: an analysis of the ATTIRE trial Nikolaj Torp; Nick Freemantle; Mads Israelsen; Aleksander Krag; Alastair O¿Brien;

Prevalence and risk factors of significant fibrosis in chronic hepatitis B patients with concurrent metabolic dysfunction-associated steatotic liver disease Shan Hong; Yiwei Hao; Lei Sun; Ping Li; Junru Yang; Fuyang Zhang; Lingling He; Jing Zhang; Hongshan Wei;

Palliative care and end stage liver disease: A cohort analysis of palliative care use and factors associated with referral Hugo M Oliveira; Helena Pessegueiro Miranda; Francisca Rego; Rui Nunes;